Xi'an Kintai Biotech Inc is one of the most experienced manufacturers and suppliers of palmitoylethanolamide pea powder in China. Please feel free to wholesale high quality palmitoylethanolamide pea powder for sale here from our factory. For price consultation, contact us.
Palmitoylethanolamide PEA Powder manufacturer / supplier
The Palmitoylethanolamide (PEA) powder produced by KINTAIBIO® is a high-purity, endogenous fatty acid amide active ingredient. It appears as a white to off-white crystalline powder, offering excellent stability and biocompatibility. With a purity of 99% or higher, the product supports customization regarding particle size, packaging formats, and OEM/ODM services. Thanks to its unique physiological activity, PEA powder is widely used in the development of various products.
Palmitoylethanolamide occurs naturally in various human tissues and cells, playing a crucial role-particularly within the nervous system, immune cells, and tissues associated with inflammation. As a bioactive lipid molecule, PEA participates in the regulation of inflammatory responses, neuroprotection, and pain management, primarily by modulating signaling pathways such as the peroxisome proliferator-activated receptor alpha (PPAR-α). In recent years, driven by growing consumer demand for natural health ingredients and non-pharmacological interventions, Palmitoylethanolamide Powder has emerged as a highly sought-after functional nutritional ingredient in the global market.
Contact Us Now To Get The Free Samples!
Palmitoylethanolamide PEA Powder is obtained through two main methods: natural extraction and chemical synthesis. Current industrial production typically employs advanced synthetic processes to ensure high purity, batch-to-batch consistency, and the capacity for large-scale supply. We maintain a rigorous raw material sourcing system and a comprehensive quality control process, managing every stage from raw material procurement and processing to finished product testing. Each batch undergoes compositional analysis-using methods such as HPLC-to guarantee consistent active ingredient levels. We also provide COA, MSDS, and other relevant quality documentation upon request; please contact sales@kintaibio.com for more information.
COA Of Palmitoylethanolamide PEA Powder
what are the benefits of palmitoylethanolamide PEA powder ?
palmitoylethanolamide pain
Palmitoylethanolamide (PEA) has garnered sustained research interest in the field of chronic pain management. Extensive studies indicate that PEA holds potential therapeutic value in managing neuropathic pain, pain associated with chronic inflammation, and certain types of mixed pain.
It functions primarily by modulating the body's endogenous lipid signaling systems-including the activation of peroxisome proliferator-activated receptor alpha (PPAR-α), the regulation of mast cell activation, and the modulation of neuroinflammation-related pathways-thereby helping to reduce the release of inflammatory mediators, alleviate neuronal hypersensitivity, and support neurological homeostasis. Unlike conventional analgesics that act directly on pain transmission pathways, Palmitoylethanolamide PEA Powder operates by modulating inflammatory responses and neuro-immune interactions, offering a novel nutritional intervention strategy for the long-term management of chronic pain.
palmitoylethanolamide for dogs
Palmitoylethanolamide PEA Powder also demonstrates significant potential in the field of animal health management. Classified as a fatty acid amide associated with Autacoid Local Injury Antagonism (ALIA), PEA participates in maintaining the balance of immune responses and inflammatory processes through the body's endogenous regulatory mechanisms.
Research indicates that PEA can regulate inflammatory cell activity, modulate mast cell responses, and support neuro-immune homeostasis in dogs. Consequently, it is incorporated into pet nutritional supplements and functional formulas to support joint and skin health, as well as the nutritional management of issues associated with chronic inflammation.
palmitoylethanolamide anxiety
Research indicates that obesity resulting from a long-term high-fat diet can trigger systemic low-grade inflammation and further promote inflammatory responses in the central nervous system, which are associated with anxiety-like behaviors and emotional dysfunction. As an endogenous lipid mediator, PEA helps maintain neuro-immune homeostasis by modulating signaling pathways associated with peroxisome proliferator-activated receptor alpha (PPAR-α); this action reduces the release of inflammatory cytokines and attenuates the overactivation of microglia and astrocytes.
Relevant animal studies demonstrate that PEA supplementation can alleviate anxiety-like behaviors in obese mice while lowering levels of pro-inflammatory mediators such as TNF-α and IL-1β. Furthermore, it positively influences the aberrant activation of the hypothalamic-pituitary-adrenal (HPA) axis, neurotransmitter balance, and blood-brain barrier function. These findings suggest that Palmitoylethanolamide PEA Powder-by mitigating neuroinflammation, supporting neuroprotection, and modulating the cerebral microenvironment-offers a novel nutritional intervention strategy for maintaining emotional health and neurological function.
palmitoylethanolamide weight loss
Palmitoylethanolamide (PEA), a naturally occurring endogenous lipid mediator, has recently demonstrated potential value in the fields of weight management and metabolic health. Research indicates that obesity is not only linked to an imbalance between energy intake and expenditure but is also accompanied by chronic low-grade inflammation (metabolic inflammation); this inflammatory response plays a significant role in adipose tissue dysfunction, reduced insulin sensitivity, and metabolic abnormalities.
PEA possesses biological activity that modulates inflammatory responses and lipid metabolism. By influencing pathways such as peroxisome proliferator-activated receptor alpha (PPAR-α), it participates in the regulation of energy balance and may help alleviate obesity-related inflammation. Studies and reviews suggest that Palmitoylethanolamide PEA Powder holds promise for obesity management in both humans and animals; it may offer nutritional support for weight management and metabolic health by regulating appetite, supporting lipid metabolism, and reducing levels of chronic inflammation.
palmitoylethanolamide blood pressure
Research indicates that the chronic inflammation and oxidative stress associated with long-term hypertension may contribute to vascular dysfunction and target-organ damage, while palmitoylethanolamide (PEA) possesses the potential to modulate inflammatory responses and oxidative stress levels.
Relevant animal studies have shown that PEA can alleviate oxidative stress and suppress pro-inflammatory responses in hypertensive models by activating pathways associated with peroxisome proliferator-activated receptor alpha (PPAR-α). Additionally, Palmitoylethanolamide PEA Powder modulates the renin-angiotensin system (RAS)-a key regulator of blood pressure-thereby exerting a protective effect against hypertension-related renal injury.
Reference:https://pmc.ncbi.nlm.nih.gov/articles/PMC11751209/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9496254/
https://www.sciencedirect.com/science/article/pii/S088915912200037X
https://www.mdpi.com/1420-3049/31/14/2524
https://www.sciencedirect.com/science/article/abs/pii/S1043661813001229
what is Palmitoylethanolamide PEA Powder used for?
Palmitoylethanolamide Supplements
PEA is frequently used as a key functional ingredient in nutritional and health formulations. It can be developed into various dosage forms-such as Palmitoylethanolamide tablets and Palmitoylethanolamide capsules-to support joint health, exercise recovery, neurological health, and inflammation management.
Palmitoylethanolamide PEA Powder in Personal Care and Cosmetics
Due to its lipid-regulating properties and ability to support skin barrier function, PEA is used in soothing and restorative products (such as Palmitoylethanolamide creams and lotions) and is commonly incorporated into the development of skincare creams, moisturizers, functional beauty formulations, and personal care products.
Palmitoylethanolamide in Pharmaceutical Research
As a significant active research ingredient, Palmitoylethanolamide PEA Powder is widely used in studies concerning pain modulation mechanisms, immune balance, neuroprotection, and inflammation, providing the raw material foundation for the development of functional health products and innovative formulations.
Palmitoylethanolamide PEA Powder side effects,dosage,safety
Palmitoylethanolamide side effects
After decades of research, the safety and tolerability of palmitoylethanolamide (PEA) have been extensively evaluated in both human and animal studies. Numerous clinical studies have focused on PEA's applications in pain management, inflammation regulation, neurological health, and immune balance; it demonstrates a high overall safety profile with a low incidence of adverse reactions. Existing literature indicates that some subjects may experience mild, transient gastrointestinal discomfort-such as nausea, bloating, or indigestion-after PEA supplementation; however, overall tolerability is good, and no significant risk of severe toxicity has been observed.
Palmitoylethanolamide PEA Powder dosage
Specific dosages of palmitoylethanolamide vary depending on the product form, intended application, and individual circumstances. When used as an ingredient in dietary supplements, the appropriate inclusion level should be determined based on the finished product's formulation requirements and local regulations.
Palmitoylethanolamide drug interactions
No clear, severe interactions between Palmitoylethanolamide PEA Powder and common medications have been identified to date. However, given that PEA may be involved in inflammation regulation and immune-related pathways, individuals undergoing long-term medication, as well as pregnant or breastfeeding women and those with specific health conditions, are advised to use it under professional guidance; a cautious approach is recommended for these specific populations.
where to buy palmitoylethanolamide ?
If you are looking for high-quality palmitoylethanolamide for sale, KINTAIBIO® is a trusted supplier of PEA powder. As a professional manufacturer of PEA raw materials, we employ a comprehensive production system and rigorous quality management processes to ensure our PEA powder offers high purity, stability, and batch-to-batch consistency. In addition to standard Palmitoylethanolamide PEA Powder, we provide professional documentation-including COAs, MSDSs, and relevant quality test reports-to support specific formulation and development needs.
With extensive international supply experience, KINTAIBIO® is dedicated to providing stable and reliable PEA raw material solutions to customers worldwide. If you are searching for a reliable Palmitoylethanolamide Powder Manufacturer and Supplier, please contact us at sales@kintaibio.com for product specifications, pricing, and sample availability.
FAQ
Q: Does palmitoylethanolamide lower cholesterol?
A: Currently, there is insufficient clinical evidence in humans to prove that PEA directly lowers blood cholesterol levels; therefore, it cannot be positioned as a cholesterol-lowering product. However, some studies suggest that PEA may influence metabolic health by modulating lipid metabolism, inflammatory responses, and PPAR-related pathways. Since PPAR-α is involved in fatty acid oxidation and the regulation of lipid metabolism, PEA holds research value in the field of metabolic health. For companies looking to develop products for cardiovascular health or metabolic management, PEA is better suited as a functional ingredient that supports inflammatory balance and overall health, rather than as a traditional lipid-lowering agent.
Q: Can palmitoylethanolamide cause weight gain?
A: There is currently no research evidence indicating that PEA causes weight gain. On the contrary, some animal studies suggest that PEA may play a role in regulating energy metabolism and positively influencing obesity-related inflammatory states. Obesity is often accompanied by chronic low-grade inflammation (metabolic inflammation), and PEA has the potential to modulate inflammatory responses and lipid signaling pathways. Research indicates that PEA may support weight management and metabolic health by activating PPAR-α, influencing fat metabolism, and regulating levels of inflammatory cytokines. It is important to note that PEA is not a weight-loss drug and cannot replace dietary control and exercise. In the realm of weight management, it serves primarily as a functional nutritional ingredient for use in health management products.
Q: Is palmitoylethanolamide the same as phenylethylamine?
A: No. Although Palmitoylethanolamide (PEA) and Phenylethylamine (PEA) share the same English acronym, they are completely different compounds. Palmitoylethanolamide: Chemical class: Fatty acid ethanolamide; Molecular type: Endogenous lipid molecule; Primary research areas: Inflammation regulation, pain management, neurological health. Phenylethylamine: Chemical class: Monoamine neurotransmitter; Primary involvement: Neurotransmitter regulation and mood-related research. Because both share the acronym PEA, confusion can easily arise during international procurement and literature searches. Therefore, when purchasing palmitoylethanolamide powder, one should clearly verify that the product name is "Palmitoylethanolamide Powder."
Hot Tags: palmitoylethanolamide pea powder, China palmitoylethanolamide pea powder manufacturers, suppliers, factory
